Treatments & Interventions
Vitamin D>3<
substance
Opium
substance
Laudanum
substance
Azathioprine sodium
substance
Thalidomide
substance
Para-aminosalicylic acid
substance
Azathioprine
substance
Infliximab
substance
Methotrexate
substance
Adalimumab
substance
Methotrexate sodium
substance
Natalizumab
substance
Certolizumab pegol
substance
Ustekinumab
substance
Vedolizumab
substance
Obiltoxaximab
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Aphthous stomatitis
HP:0011107
Aphthous ulcer
HP:0032154
Bowel obstruction
HP:0005214
Crohn's disease
HP:0100280
Diarrhea
HP:0002014
Inflammation of the large intestine
HP:0002037
Intestinal fistula
HP:0100819
Stomach pain
HP:0002027
Ulcerative colitis
HP:0100279
Very poor growth
HP:0001510
Weight loss
HP:0001824
Quick Facts
- SNOMED CT
- 34000006
- UMLS CUI
- C0010346
- Fully Specified Name
- Crohn's disease (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 11
- Known Treatments
- 16
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.